These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 3803260)

  • 61. Application of calcium channel blockers in the treatment of cardiovascular diseases.
    Herman ZS
    Pol J Pharmacol; 1999; 51(2):201-6. PubMed ID: 10425650
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Advances in the treatment of cardiovascular disease.
    Lawrie TD
    Practitioner; 1969 Oct; 203(216):460-7. PubMed ID: 4901132
    [No Abstract]   [Full Text] [Related]  

  • 63. [Calcium antagonists in the treatment of coronary heart disease].
    Rafflenbeul W
    Fortschr Med; 1984 Jul; 102(27-28):718-21. PubMed ID: 6479814
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Calcium channel blockers in the treatment of cardiovascular disease].
    Halawa B
    Pol Merkur Lekarski; 2001 Jul; 11(61):83-7. PubMed ID: 11579840
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Calcium-blockers or calcium antagonists].
    Chávez Rivera I
    Arch Inst Cardiol Mex; 1982; 52(3):259-67. PubMed ID: 7052003
    [No Abstract]   [Full Text] [Related]  

  • 66. Calcium channel blockers.
    Deedwania PC
    West J Med; 1982 Jul; 137(1):24-31. PubMed ID: 6291255
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Beta-adrenergic inhibitors and coronary insufficiency].
    Juliard JM; Dahan M; Cohen Solal A; Gourgon R
    Therapie; 1985; 40(6):393-6. PubMed ID: 2868533
    [No Abstract]   [Full Text] [Related]  

  • 68. Clinical outcome studies of anti-anginal drug therapy for patients with stable coronary disease: an indication for clinical trials.
    Parker JD
    Eur Heart J; 1998 Aug; 19 Suppl I():I15-9. PubMed ID: 9743439
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Therapy of coronary heart disease with calcium antagonists in clinical practice].
    Bleifeld W; Spokojny A
    Med Welt; 1983 Nov; 34(47):1335-9. PubMed ID: 6656569
    [No Abstract]   [Full Text] [Related]  

  • 70. [Calcium antagonists in the therapy of ischemic heart disease].
    Makolkin BI; Vakhliaev VD
    Klin Med (Mosk); 1994; 72(1):4-7. PubMed ID: 8196322
    [No Abstract]   [Full Text] [Related]  

  • 71. Clinical pharmacology of calcium entry blockers.
    Bianchi CP
    Cardiovasc Clin; 1983; 14(1):123-8. PubMed ID: 6311420
    [No Abstract]   [Full Text] [Related]  

  • 72. Calcium channel blockers: indications and limitations 2. Use in angina and other cardiac disorders.
    Karlsberg RP; Aronow WS
    Postgrad Med; 1982 Nov; 72(5):115-7, 120, 123. PubMed ID: 6215636
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Criteria of the clinical application of Ca++ antagonists].
    Kishida H; Saito H; Hayakawa H
    Nihon Rinsho; 1982; 40(11):2477-83. PubMed ID: 6218317
    [No Abstract]   [Full Text] [Related]  

  • 74. [Anti-arrhythmia therapy with Ca++-antagonists].
    Fazekas T
    Orv Hetil; 1989 Jun; 130(23):1195-200. PubMed ID: 2660063
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Understanding the calcium channel blockers.
    Stone KS; Scordo KA
    Heart Lung; 1984 Sep; 13(5):563-73. PubMed ID: 6088433
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Controversy about using calcium antagonists for treatment of coronary disease and hypertension].
    Głuszek J; Pawlaczyk-Gabriel K
    Przegl Lek; 1997; 54(9):597-601. PubMed ID: 9501678
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Pharmacological aspects of calcium channel blockers: therapeutic implications].
    Mill JG; Vassallo DV; Vasquez EC
    Arq Bras Cardiol; 1987 Apr; 48(4):255-65. PubMed ID: 3328598
    [No Abstract]   [Full Text] [Related]  

  • 78. [Therapy of the functionally disturbed heart with regard to its vascular and nervous supply].
    Leonard W
    Hippokrates; 1968 Jan; 39(2):69-72. PubMed ID: 5716576
    [No Abstract]   [Full Text] [Related]  

  • 79. The use of beta adrenergic blocking drugs in cardiovascular disease.
    Prichard BN
    Scott Med J; 1976 Oct; 21(4):182-7. PubMed ID: 11558
    [No Abstract]   [Full Text] [Related]  

  • 80. The use of diltiazem hydrochloride in cardiovascular disorders.
    McAuley BJ; Schroeder JS
    Pharmacotherapy; 1982; 2(3):121-33. PubMed ID: 6763199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.